ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 664701 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 664701; 2) Community: the network communities that were significantly associated with the response to NSC 664701; 3) Molecule: the relationships between components within communities and NSC 664701; 4) MDR: the compounds that were significantly associated with the NSC 664701.

NSC Compound Enrichment Correlation
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.0138010872611484 0.31256227
NSC 740 Methotrexate 0.0138010872611484 0.55487421
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.0138010872611484 0.39018469
NSC 756404 GW843682X 0.0138010872611484 0.34675613
NSC 119875 Cisplatin 0.0138010872611486 0.29689141
NSC 139105 Soluble Baker's Antifol 0.0138010872611486 0.43149271
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0138010872611486 0.33901639
NSC 179187 Salasdine 0.0138010872611486 0.22654896
NSC 268242 N,N-Dibenzyldaunorubicin 0.0138010872611486 0.50147712
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0138010872611486 0.23976935
Total:98  Current:42    [First] [Prev] [Next] [Last]